A rapid and sensitive chemiluminescence (CL) method using flow-injection (FI) has been developed for the determination of mandelic acid which is based on the enhancement of mandelic acid to the CL intensity of Ru(bipy)3 2+ -Ce(IV) system. The enhancement effect was dependent on the concentration of mandelic acid, based on which, CL system was established for the determination of mandelic acid. The concentrations of Ru(bipy)3 2+ , Ce(IV), and H2SO4 were optimized. Under the optimum experimental conditions, the linear range and detection limit are 1.46-342.0 μg/mL and 0.072 μg/mL, respectively. The correlation coefficient (R) was 0.99732. The utility of this method was demonstrated by determining mandelic acid in capsules and human urine sample.
Introduction
Mandelic Acid (MA), phenylglycollic acid, is an alphahydroxy acid (AHA) (Figure 1 ) which has a hydroxyl group on the carbon atom next to the acid group. In human, MA is a major metabolite of styrene and used as biological indicator of occupational exposure to styrene. 1 In plastic industries, styrene is widely used and has been implicated as reproductive toxicant, neurotoxicant and possible carcinogen. In human and rodents, styrene can be metabolized to styrene epoxide (SO) by the microsomal cytochrome P-450 dependent liver monooxygenase and further metabolized to 1,2-phenylethanediol by epoxide hydrolase, then 1,2-phenylethanediol can be metabolized to MA that is excreted in urine. 2 Recent studies indicated that styrene epoxides accounted for the styrene toxicity and contribute to the genotoxicity of styrene in human blood lymphocytes. 3 Both styrene epoxide and 1,2-phenylethanediol are chirals and show stereo-selectivity in metabolism in vivo leading to different urinary excretions of MA enantiomers. 4 MA and its derivatives are a type of chiral synthons which are useful for the production of different pharmaceuticals, such as cephalosporins, antiobesity agents, semisynthetic penicillins and antitumor agents. 5, 6 The few reported methods for the determination of MA are HPLC, 7 gas-chromatography, 8, 9 capillary electrophoresis, 10 electrochemiluminescence 11 and spectrophotometry. 12 Chemiluminescence (CL) methods provide many advantages for pharmaceutical determinations such as high sensitivity, high selectivity, and small amount of chemical consumption, cost effectiveness, simple sample preparation and instrumentation. [13] [14] [15] Tris (2,2′-bipyridyl) ruthenium(II) has been used as the basis of CL detection of a wide range of compounds after oxidation to the ruthenium(III) complex. 16 The analyte interacts with the ruthenium(III) complex reducing it to the ruthenium(II) complex in an excited state, which then emits CL as it returns to the ground state. In the present study, a flow injection procedure for MA determination with CL detection was proposed in which ruthenium(II) was oxidized by Ce(IV) solution. The CL emission intensity depended on the concentration of the analyte in the CL system. This work describes a relatively sensitive, rapid and reproducible CL method for MA determination based on tris (2,2′-bipyridyl)ruthenium(II) without sample pretreatment process. To the best of our knowledge, no method has so far been reported for the determination of MA using flow-injection CL technique. The proposed method was successfully applied to the determination of MA in commercial pharmaceutical formulation. The results of recovery of MA in urine sample were satisfactory. The reaction mechanism was also proposed.
Experimental
Reagents. All chemicals were of analytical reagent grade and were used without further purification. All solutions were prepared with distilled deionised water. Mandelic acid was purchased from Sigma (St. Louis, USA). The stock solution of MA was (1×10 -2 M) prepared by dissolving 1.52 gm of MA in water and diluting to 1000 mL with water. Solutions of the desired concentrations were obtained by diluting the stock solution to a volume with water. Figure 2 . Two peristaltic pumps (Ismatec Model 404) were used to convey all solutions. Pump P 1 delivered carrier stream (H2O) at a flow rate of 2.0 mL min -1 which was incorporated with sample solution in a Rheodyne (Cotati, CA, USA) Model 7125 six-way injection valve with a loop while pump P2 was used to convey all other CL reagents at an equal flow rate of 2.0 mL min -1 for each line. PTFE tubing (0.8 mm i.d) was used throughout the manifold to carry all components. A Spex (Edison, NJ, USA) Model FL111 spectrofluorimeter equipped with a coiled glass flow cell (1.0 mm i.d., 20 mm total diameter) was used for detecting and recording the CL intensity of the reaction product. The Spex DM 3000 program was used for data acquisition and data analysis. For the CL measurement, the light source of the spectrofluorimeter was switched off. The slit width of the emission monochromator was 0.25 mm. The high voltage for the photomultiplier tube (R 928, Hamamatsu, USA) was set to 950 V.
Procedure. The FIA configuration consisted of a threechannel manifold using two pumps. The schematic diagram of the manifold is shown in Figure 2 . Prior to the CL measurement acquisition corresponding to the solution containing ruthenium (II) solution stream was mixed with acidic Ce(IV) solution stream in a three-way "T 1 " connector. The resulting stream was merged with the carrier solution in the second "T 2 " connector and then reached the flow cell in the fluorimeter, accompanying the remarkable increase of CL intensity. The full CL intensity versus time was recorded. The increase in the CL intensity produced when a solution containing the MA was incorporated into the carrier stream, in relation to the original CL signal corresponding to a blank, was proportional to the MA concentration and was used as analytical signal. This signal was measured as peak height.
Sample preparation. A total 20 tablets of Methenamine which contains mandelic acid, accurately weighed, then ground and mixed well. An appropriate amount of MA equivalent to one tablet (500 mg of Methenamine) was accurately weighed and dissolved in water by sonication in a 250 mL volumetric flask and diluting with water to 250 mL. The dissolved sample was filtered through Whatman No. 1 filter paper and diluted with water to volume to obtain the appropriate concentration for analysis. Immediately after collection, 25 mL aliquots of urine samples from 5 volunteers were spiked with MA at variable concentration levels, in order to calculate the recoveries of the proposed method. From these pools, 0.5 mL aliquots were distributed to 0.5 mL Eppendorf and stored at -18 ºC until analysis.
Results and Discussion
Selection of the concentration of Ru(bipy) 3
2+
. It is well known that for the CL system involved in Ru(bipy) 3
, the light emission is generated from the excited state species [Ru(bipy)3 2+ ] which is the reaction product of Ru(bipy) 3 3+ with the appropriate reductants, commonly the analytes, so Ru(bipy) 3 2+ is the luminophor of the system. 17 In order to find the optimum concentration of Ru(bipy) 3 2+ used for the chemiluminogenic reagent for the determination of MA, the effect of Ru (bipy) . The CL intensity increased from 3.3×10
-5 M to 6.7×10 -4 M of Ru(bipy)3 2+ and then decreased. The CL intensity increased with increasing Ru(bipy) 3 2+ concentration which can be attributed to the rapid CL reaction because of the increased reagent to analyte ratio. 18 The decreased CL intensity beyond the concentration of 6.7×10 - Figure 4 , it was seen that when the concentration of Ce(IV) increased from 3.33×10 -5 to 2.3×10 -3 M, the CL intensity of Ru(bipy)3
-Ce(IV)-MA system increased and after the concentration of Ce(IV) exceeded 2.3×10 -3 M, the intensity decreased which may be due to the absorption of light emission by the colored Ce(IV) solution and the scattering of light emission by the unsolvable hydrolysis product of Ce(IV) at the experimental acidity. 19 For this reason, 2.3×10 -3 M of Ce(IV) was selected for further experiments.
Effect of mineral acids. The effects of H 2 SO 4, HNO 3 and HCl in the Ce(IV) solution were studied. The relative intensities were 100.0, 85.2 and 55.0 % respectively. In the presence of H2SO4, CL intensity was maximum. Thus H 2 SO 4 was chosen for subsequent studies. In the solution of H 2 SO 4 , the Ce(IV) species exist as sulfated complexes, such as, Ce(SO4) Figure 5 , the maximum intensity reached at 3.3×10 -2 M H2SO4. When the H2SO4 concentration was above this level, the light intensity started to decrease which indicates that under this concentration condition, the amounts of the reactive species of the oxidants in the solution is maximum. Hence, 3.3×10 -2 M H 2 SO 4 was used for the determination of MA.
Effect of flow rate on the chemiluminescence intensity. The flow rate is an important parameter in CL detection as the time taken to transfer the excited product into the flow cell is critical for maximum collection of the emitted light. 21 In order to achieve maximum CL intensity, total flow rates between 1 and 4.5 mL min -1 were tested with equal flow rates in each channel of both pumps. CL intensity increased as the flow rate increased and reached maximum at 2.0 mL min -1 . Further increasing the flow rate did not change the analytical signal significantly. Low flow rate resulted in an increased residence time (> 41 second). It was observed that reagent consumption increased and peak shape as well as measurement rate were affected simultaneously with higher flow rate. Therefore a flow rate of 2.0 mL min -1 in each channel was recommended considering greater precision, and economy in the use of reagents.
Effect of sample volume on the chemiluminescence intensity. When the sample injection volume was varied in the range 50-400 µL, the peak height increased and reached maximum at 250 µL. After that, the height remained almost constant above this value. At very large sample volumes (> 300 µL), double peaks were observed probably due to the very high dispersion values at the edges and very low values in the centre because of limited dispersion of the carrier into the analyte and distortion in concentration gradient within the flow. A volume of 250 µL was recommended for all remaining experiments. 
Ce(IV) and 3.3×10 -2 mol L -1 H2SO4; (a) Ru(bipy)3 2+ Ce(IV) system; (b) Ru(bipy)3
-mandelic acid-Ce(IV) system. *The CL intensity of (a) is amplified 100 times.
CL kinetic curves of the systems. The CL kinetic curves of Ru(bipy) 3
-Ce(IV) and Ru(bipy) 3
-MA-Ce(IV) systems were constructed with the recorder, which are shown in Figure 6 . Ru(bipy)3 2+ -Ce(IV) system has an ultra-weak CL. Adding MA into the system can largely enhance its CL intensity and the value of enhancement is proportional to the concentration of MA added. By this property, MA can be determined sensitively with CL method.
Calibration and detection. In order to obtain a calibration curve (Figure 7 Interferences studies. Considering that the developed method would be applied to determine MA in tablets and urine sample, the interference effect of common ions and several compounds commonly used as excipients and generally presented in urine sample was assessed. Samples containing MA at a fixed concentration of 3.6×10 -4 mol/L and increasing concentration of the interferences were analyzed by the method. The tolerable limit of a foreign species was taken if it caused a relative error of less than 5%. Under the optimized conditions, the common ions and the studied excipients at concentrations usually found in the tablets did not interference the determination of MA. So the content of MA in tablet could be determined after filtration without any pretreatment.
Analytical applications. The proposed method was used to analyze urine samples from 5 volunteers. The samples were found to contain no MA, so they were spiked with MA at variable concentrations. Table 1 shows the results obtained in the determination of MA. As can be seen, the differences between the concentrations added and those found were small in all cases. Therefore, the proposed method can be reliably applied to real samples. Recoveries ranged from 94.6 to 105.0%. The proposed method was applied to the determination of MA in pharmaceutical preparations. The results obtained and the labeled contents are given in Table 2 . There were no significant differences between labeled contents and those obtained by the proposed method. Recovery studies were also performed on each of the analyzed samples by recommended treatment. Recoveries ranged from 97.5 to 102.5%. pyruvate or citrate in solution, and so the CL reaction does not proceed. [24] [25] [26] [27] Cerium (IV) has a higher reduction potential than Ru(bipy) 3 2+ and CL emission is observed in the presence of Ce(IV) because the oxidation of acids forms intermediate radicals of sufficient energy to react with the Ru(bipy)3 3+ generated from Ru(bipy) 3 2+ by oxidation with cerium(IV). In preliminary study, it was also observed that at low concentrations of Ru(bipy)3 2+ there is little or no CL emission, despite the presence of the optimized Ce(IV) concentration. By analogy the scheme proposed for MA is:
The mechanism involves the oxidation of Ru(bipy) 3 2+ and MA by Ce(IV). The oxidation product of acid undergoes decomposition to form a radical. This reduces the Ru(bipy) 3 3+ to the excited state that subsequently emits light (610 nm) with the formation of benzaldehyde as by-product.
Conclusion
The proposed chemiluminescence detection method has proved to be simple, rapid and sensitive for MA determination. This preliminary study shows that mandelic acid exhibits analytically useful chemiluminescence upon reaction with tris (2,2'-bipyridyl) ruthenium(II) and acidic Ce(IV). The linear range and detection limit are 1.46-342.0 µg/mL and 0.072 µg/ mL, respectively. The chemiluminescence method proposed here is relatively simple and showed significant selectivity. The results indicated that the proposed chemiluminescence reaction system is not only appropriate for flow injection analysis but is also convenient for batch type systems due to intense chemiluminescence signal. Utilizing the proposed method, the MA content of commercial tablets as well as in urine sample can be determined with reasonable selectivity. 
